SAvvyWire™ EFficacy and SafEty in Transcatheter Aortic Valve Implantation Procedures (SAFE-TAVI)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 119 participants.

Also called NCT05492383

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose other
Phase
Not applicable
Enrolled
  • 119 participants (enrolled count) (from the registry)
Sponsor
Opsens, Inc. (from the registry)
Registry
  • NCT NCT05492383
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05492383. Allocation not applicable; no masking; primary purpose other. Start 2022-10-25 (actual); primary completion 2023-03-03 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
SAvvyWire™ EFficacy and SafEty in Transcatheter Aortic Valve Implantation Procedures (SAFE-TAVI)
Acronym
SAFE-TAVI
Condition
Severe Aortic Stenosis
Intervention (Device)
TAVI
Lead sponsor
Opsens, Inc. (class: industry)

Record details

Record id
cardio:ct-nct05492383
Content hash
c622dbdabcd46f3f7bc954f0112500200a214bd01e7f73e5487cd6152da329b5